v3.26.1
Share Based Compensation (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]    
Schedule of Restricted Stock Activity  

The following table summarizes restricted stock activity for the 2023 Plan:

 

   Number of Awards   Weighted Average Grant Date Fair Value Per Unit 
Outstanding at December 31, 2024   -   $- 
Granted   52   $3,480 
Cancelled/forfeited   -   $- 
Vested   (52)  $(3,480)
Outstanding at December 31, 2025   -   $- 
Schedule of Fair Value of Stock Option Granted  

The Company estimated the fair value of stock options granted in the periods presented using a Black-Scholes option-pricing model utilizing the following weighted-average assumptions:

 

    For the year ended December 31,  
    2025     2024  
Expected volatility (%)     158.5 %     83.9 %
Expected term (years)     10.0       5.5  
Risk-free interest rate (%)     4.22 %     4.32 %
Expected dividend yield (%)     0 %     0 %
Schedule of Stock Option Activity

The following table summarizes stock option activity for the 2023 Plan:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

(years)

  

Aggregate

Intrinsic

Value

(in thousands)

 
Outstanding at December 31, 2025   25   $195,153    8.74   $              - 
Granted   -   $-    -   $- 
Cancelled/forfeited   -   $-    -   $- 
Exercised   -   $-    -   $- 
Outstanding at June 30, 2026   25   $195,153    7.97   $- 
Exercisable   24   $120,540    8.14   $- 
Unvested   1   $1,908,034    7.60   $- 

The following table summarizes stock activity for the 2023 Plan:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

(years)

  

Aggregate

Intrinsic

Value

(in thousands)

 
Outstanding at December 31, 2024   2   $2,445,600    9.72   $             - 
Granted   23   $3,780    -   - 
Cancelled/forfeited   -  $3,419,880    -   - 
Exercised   -   $-    -   - 
Outstanding at December 31, 2025   25   $199,140    8.74   $- 
Exercisable   24   $124,600    8.64   $- 
Unvested   1   $3,097,400    8.23   $-